Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy

Abstract

The development of resistance to endocrine therapy is a significant, clinical problem in breast cancer. Here, the authors identify a rare subpopulation of cells that drive resistance following transcriptional reprogramming.